Nectar Lifesciences Ltd - 532649 - Shareholding for the Period Ended June 30, 2021
Nectar Lifesciences Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2021. For more details, kindly Click here06-07-2021
06-07-2021
Nectar Lifesciences Ltd - 532649 - Statement Of Investor Complaints For The Quarter Ended June 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0220 Name of the Signatory :- DINESH DUADesignation :- Managing Director / Whole Time Director05-07-2021
NECTAR LIFESCIENCES LTD. - 532649 - Statement Of Investor Complaints For The Quarter Ended June 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0220 Name of the Signatory :- DINESH DUADesignation :- Managing Director / Whole Time Director05-07-2021
Nectar Lifesciences Ltd - 532649 - Closure of Trading Window
Pursuant to Code of Conduct as per Regulation 9 of Securities & Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, and in continuation to our letter no. NLL/CS/2021-387 dated March 30, 2021, we wish to inform you that the trading window of the Company will further continue to be closed till 48 hours after the declaration of Financial Results for the Financial Year 2020-21 or for the quarter ended on June 30, 2021, whichever is later.29-06-2021
Nectar Lifesciences Ltd - 532649 - Results-Delay in Financial Results
The company is not able to submit financial results for the quarter and year ended on March 31, 2021 by June 30, 2021 as per the detailed reason provided in attached letter.29-06-2021
Nectar Lifesciences Ltd - 532649 - Announcement under Regulation 30 (LODR)-Resignation of Director
Resignation of Mr Maj. Gen. (Retd.) Dr. Ajit Singh Dhillon as Independent Director of the company w.e.f. Jun 24, 2021.25-06-2021
NECTAR LIFESCIENCES LTD. - 532649 - Resolution Plan Under One Time Restructuring Pursuant To Reserve Bank Of India'S Notifications Under The 'Resolution Framework For COVID-19 Related Stress'
We would like to inform that Company and its Lenders on June 21, 2021 have executed the documents with respect to the resolution plan under One Time Restructuring ('OTR') pursuant to Reserve Bank of India's notifications under the 'Resolution Framework for COVID-19 related Stress' and same has been implemented from June 21, 2021.22-06-2021
Nectar Lifesciences Ltd - 532649 - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that Ms. Sukriti Saini has resigned from the post of Company Secretary and Compliance Officer of the Company with effect from June 15, 2021.15-06-2021
Nectar Lifesciences Ltd - 532649 - Disclosure Received In Terms Of Regulation 7(3) Of SEBI (Prohibition Of Insider Trading) Regulation, 2015 ('PIT Regulations').
Please be informed that the company has received disclosures under captioned regulation in form D from SBICAP TRUSTEE COMPANY LIMITED (SBICAP), acting as the Security Trustee of the Lenders of the Nectar Lifesciences Limited ('Company'), in whose favor the promoters of the Company have pledged their entire holding in the Company. The promoters and the Company have already made the necessary disclosures under regulation 7(2) of PIT Regulations.03-06-2021
Nectar Lifesciences Ltd - 532649 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for SBICAP Trustee Company Ltd02-06-2021